The downregulation of RFX1 contributes to DNA hypomethylation and histone H3 hyperacetylation at the CD11a and CD70 promoters in CD4+ T cells of patients with SLE, which trigger immune responses [66]. Here, CD70 is linked to systemic lupus erythematosus.